Introduction
Since cells are encapsulated in a large amount of mucus in airway secretions, the functional assessment of leukocytes by an in vitro assay has been hindered. Dithiothreitol (DTT) is the most common lysis buffer to dissociate and homogenize the sputum for cytological analysis and detection of mediators while providing tolerable viability of isolated cells 1, 2 . However, DTT can interfere with surface-bound antigens of airway neutrophils, resulting in the disruption of neutrophil function such as elastase and myeloperoxidase (MPO) release 2, 3 .Therefore, few studies of human airway neutrophil function have been conducted with peripheral blood neutrophils, which may not reveal the physiological characteristics of pulmonary 4 . Meanwhile, inertial microfluidics has made advances in isolating cells from various patient biomatrices 5, 6 .The equilibrium between inertial lift forces and Dean drag aligns the particle/cell according to their size, which allows label-free particle separation 7 . Our group previously introduced a sample preparation method for circulating tumor cells 8, 9 , pathogens in blood 8 , cells from a suspension culture 10, 11, 12 , and polymorphonuclear leukocytes (PMNs) from blood 13, 14 .
Here, we introduce a protocol to prepare immune cells from a patient's airway secretions using closed-loop inertial microfluidics for a downstream in vitro assay, such as the neutrophil elastase (NE) assay. This method provides both high concentration and recovery, especially when there is a significant overlap in the lateral direction of the cell/particle from which the cell/particle-of-interest is to be removed, which is commonly observed in clinical samples. By recirculating the Inner wall (IW)-focused large particles or cells back to the input sample tube, the particle or cell-of-interest concentrates in the original reservoir, while background fluids with small mucin aggregates pass through the waste reservoir. Despite the heterogeneous fluidic properties of clinical samples, the proposed method recovers consistently above 95% of neutrophils from airway secretion samples that are diluted 1,000-fold with a clean saline solution (~1 mL). By contrast, the lysis method presents a wide range of PMNs recovery rates depending on the sample condition. The proposed protocol captures leukocytes in a label-free manner with no physical or chemical disruption, which provides the possibility to harvest delicate cells from clinically challenging biometrics with minimally invasive procedures.
Representative Results
We achieved transparent immune-cell suspensions with both DTT mucolysis and microfluidics dissociation ( Figure 3A) . Microfluidics dissociation collected 4.40 x 10 5 PMNs on average (2.1 x 10 4 to 5.60 x 10 5 PMNs, n = 6) from airway secretion samples diluted 1,000-fold (50 mL total volume) in 1 mL of clean suspension. Compared to the initial diluent, 94.0% PMNs (CD66b + /CD45 + ) were recovered in a small volume, consistently over 6 clinical samples. However, the DTT mucolysis method showed a 53.5% recovery on average with significant sample-tosample variations (30.8 -96.0%) ( Figure 3B ).
Next, the release of elastase was examined with a commercial NE assay kit as a proof-of-concept. Without external stimulation, the sample prepared by the mucolytic method showed a higher NE level than the sample from the microfluidics method. PMA was added to the resulting suspensions from both the microfluidics and mucolytic dissociation methods to trigger the NE release. We tested each method with airway secretion samples from 6 different patients. Immune cells separated with microfluidics presented intact functionality, showing an increased amount of NE release by PMA stimulation. On the other hand, cells prepared by the mucolytic dissociation method showed an inconsistent increase of NE release ( Figure 3C ). 
Discussion
In inertial microfluidics, particle and cells localize at a certain lateral position in a micro-channel based on their size 5, 18, 19, 20 . Due to the combined effect of the Dean drag force and the inertial lift force in the curved microchannel, large particles or neutrophils (>10 µm) are located inside the channel and small particles, mucus aggregates, and debris smaller than 6 µm are positioned outside the channel at certain flow velocity conditions 10, 11, 13, 14 .
However, there is a trade-off between the concentration and recovery of the separation when using microfluidics, especially when the separation size range of the particle or the cell of interest overlaps with other cells/particles. To achieve a high concentration of sorted particles and cells, the separation range needs to be narrow and requires a fine-tuning with microscopic observation for each sample run; this limits the usage of inertial microfluidics on heterogeneous biometrics, such as airway secretions.
Here, we introduce a clinical airway secretions sample preparation method for in vitro assays using closed-loop inertial microfluidics (Figure 1B,  C) . The closed-loop operation by recirculation of the particle/cell through a focusing outlet achieved both high concentration factors and high recovery rates. The OW outlet flows into the waste tube, and the IW outlet is continuously fed to the original sample tube. Cells larger than 10 µm in diameter remain in the initial sample tube, thus, increasing the cell density of the sample, while the background fluid is eliminated to the waste tube. The high dilution rate allows clearance of the background fluid, including debris and mucus. Also, regardless of the condition of patient sample, the proposed method can uniformly dissociate and isolate immune cells.
DTT is a widely used mucin lysis buffer that cleaves disulfide bonds in proteoglycan aggregation to separate cell content from the mucilage 1, 21, 22 . However, DTT reportedly interferes with the white blood cell surface antigens, which can affect leukocyte function 2 . In our study, the cellular contents recovered by DTT dissociation were inconsistent across samples, because of non-uniform mucolytic efficiency and clogging of the filter. This becomes more critical for the preparation of initial samples with small volumes and relatively thick airway secretion samples. On the other hand, the method using microfluidics enabled the consistent recovery of cell contents in heterogeneous patient samples ( Figure 3C ). As shown in Figure 3B , we could consistently isolate the cell contents of the airway secretion in a clean buffer regardless of the original sample state, i.e., bloody, tenacious, or watery. Compared to the conventional method, the proposed method has less debris in the recovered sample, which minimizes possible interference of debris in downstream biochemical analyses.
NE release was examined to evaluate the functional integrity of captured neutrophils by both enrichment methods ( Figure 3D) . Neutrophils remove foreign organic molecules through NE release 23, 24, 25 . PMA is commonly used to activate neutrophils in vitro 26 . Cells isolated by the microfluidics and the mucolytic (DTT) methods were stimulated with 50 nM of PMA. We tested each method with human airway secretion samples (labeled as P173, P174, P176, P177, P181, and P182). Samples concentrated by microfluidics showed an increase in NE by PMA stimulation for all 6 samples. In contrast, only 3 of the DTT treated samples could induce increased NE activity after PMA stimulation. In addition, the neutrophils isolated by the DTT mucolytic method showed much higher baseline activity than the neutrophils isolated by microfluidics. These results showed possible chemical disturbance of the NE machinery, i.e., disruption of the surface bound antigen 2, 3 
